Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc. (TBPH), sold 3,281 shares at $8.93 ($29K) on 2022-05-23, disclosed to the SEC on 2022-05-24.
Scheduled sale ($29k) by SVP, COMM & MEDICAL AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.74 | 2,200 | $19K | 66.6% |
| 2 | $8.93 | 1,081 | $10K | 33.4% |
| Total | $8.80 avg | 3,281 | $29K | 100% |
| Filing → |
| TBPH | SELL | 2026-03-18 | $650K | — | Filing → |
| TBPH | SELL | 2025-12-05 | $1.2M | — | Filing → |
| TBPH | SELL | 2025-07-16 | $174K | — | Filing → |